Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Roche lung cancer drug Alecensa slashes brain risk in tests

      Roche lung cancer drug Alecensa slashes brain risk in tests

      Ruby Khatun Khatun6 Sept 2017 10:17 AM IST
      Patients taking Roche’s targeted lung cancer drug Alecensa have a far lower risk of their disease spreading in the brain than those on Pfizer’s...
      IDFC Alternatives invests Rs 75 crore in eye care chain ASG Hospitals

      IDFC Alternatives invests Rs 75 crore in eye care chain ASG Hospitals

      Ruby Khatun Khatun6 Sept 2017 10:01 AM IST
      Mumbai: IDFC Alternatives has signed an agreement to invest Rs 75 crore in eye care chain ASG Hospitals. The investment will be pumped in through IDFC...
      German Merck considers sale of consumer health business

      German Merck considers sale of consumer health business

      Ruby Khatun Khatun6 Sept 2017 9:42 AM IST
      FRANKFURT/COLOGNE: Germany's Merck KGaA is considering selling its $1 billion consumer health unit to meet its financial targets as a decline in its...
      Indian-origin Dr Vasant Narasimhan to head Novartis, 48 billion dollar pharma giant

      Indian-origin Dr Vasant Narasimhan to head Novartis, 48 billion dollar pharma giant

      Ruby Khatun Khatun5 Sept 2017 1:56 PM IST
      ZURICH: Novartis Chief Executive Joseph Jimenez will retire in 2018, with chief drug developer Vasant Narasimhan taking over as CEO starting in...
      Sayre Therapeutics raises 8 million dollar from Accel, Aarin Capital

      Sayre Therapeutics raises 8 million dollar from Accel, Aarin Capital

      Ruby Khatun Khatun5 Sept 2017 11:34 AM IST
      Mumbai: Sayre Therapeutics, a super- specialty pharma company, on Monday said it has raised USD 8 million across two rounds of funding from Accel...
      Lupin launches generic hypertension drug in US market

      Lupin launches generic hypertension drug in US market

      Ruby Khatun Khatun5 Sept 2017 10:37 AM IST
      New Delhi: Drug maker Lupin on Monday announced the launch of its Olmesartan Medoxomil tablets, a hypertension drug, in the US market.The company has...
      Pfizer gets FDA approval for Mylotarg to treat acute myeloid leukemia

      Pfizer gets FDA approval for Mylotarg to treat acute myeloid leukemia

      Ruby Khatun Khatun5 Sept 2017 10:21 AM IST
      The U.S. Food and Drug Administration (FDA) approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid...
      Teva gets FDA approval for AUSTEDO tablets to treat Tardive Dyskinesia in adults

      Teva gets FDA approval for AUSTEDO tablets to treat Tardive Dyskinesia in adults

      Ruby Khatun Khatun5 Sept 2017 10:16 AM IST
      JERUSALEM: Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved AUSTEDO®(deutetrabenazine)...
      FDA clears mammography device with option for patient-assisted compression

      FDA clears mammography device with option for patient-assisted compression

      Ruby Khatun Khatun5 Sept 2017 9:56 AM IST
      The U.S. Food and Drug Administration (FDA) cleared the first 2D digital mammography system that allows patients to increase or decrease the amount of...
      Ozone Group partners Brazils Embelleze for hair care products

      Ozone Group partners Brazils Embelleze for hair care products

      Ruby Khatun Khatun5 Sept 2017 9:21 AM IST
      New Delhi: Pharma and FMCG firm Ozone Group announced its foray into the professional hair care segment by partnering Brazil's Embelleze.Ozone Organic...
      Sun Pharma sees single-digit decline in revenues for FY18

      Sun Pharma sees single-digit decline in revenues for FY18

      Ruby Khatun Khatun4 Sept 2017 1:31 PM IST
      Mumbai: Pharma major Sun Pharmaceutical Industries said its short-term outlook continues to be challenging and expects a single-digit decline in...
      Zydus Cadila gets USFDA nod for Mycophenolate Mofetil

      Zydus Cadila gets USFDA nod for Mycophenolate Mofetil

      Ruby Khatun Khatun4 Sept 2017 11:00 AM IST
      New Delhi: Cadila Healthcare said its group firm Zydus Cadila has received final approval from the USFDA to market Mycophenolate mofetil for injection...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok